Published in J Allergy Clin Immunol on December 25, 2013
Grass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy. Clin Exp Allergy (2014) 1.49
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J (2015) 1.03
Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals. Eur J Immunol (2015) 0.82
Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy. Clin Exp Allergy (2016) 0.81
Effect of allergen-specific immunotherapy on CD4+ T cells. Curr Opin Allergy Clin Immunol (2015) 0.79
Development and Function of Protective and Pathologic Memory CD4 T Cells. Front Immunol (2015) 0.79
Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization. J Allergy Clin Immunol (2015) 0.78
Biomarkers for antigen immunotherapy in allergy and type 1 diabetes. Clin Immunol (2015) 0.78
Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy. Clin Exp Allergy (2015) 0.77
The future of biologics: applications for food allergy. J Allergy Clin Immunol (2015) 0.77
Der p1 and Der p2-Specific T Cells Display a Th2, Th17, and Th2/Th17 Phenotype in Atopic Dermatitis. J Invest Dermatol (2015) 0.77
Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol (2016) 0.76
New strategies for allergen T cell epitope identification: going beyond IgE. Int Arch Allergy Immunol (2014) 0.76
Allergen-Specific CD4(+) T Cells in Human Asthma. Ann Am Thorac Soc (2016) 0.75
T Cell Epitope Peptide Therapy for Allergic Diseases. Curr Allergy Asthma Rep (2016) 0.75
Poor association of allergen-specific antibody, T- and B-cell responses revealed with recombinant allergens and a CFSE dilution-based assay. Allergy (2015) 0.75
Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy. J Allergy Clin Immunol (2015) 0.75
Major Histocompatibility Complex Class II Dextramers: New Tools for the Detection of antigen-Specific, CD4 T Cells in Basic and Clinical Research. Scand J Immunol (2015) 0.75
Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining. Nat Commun (2016) 0.75
Blomia tropicalis allergen 5 (Blo t 5) T-cell epitopes and their ability to suppress the allergic immune response. Immunology (2017) 0.75
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol (2007) 12.72
T cell exhaustion. Nat Immunol (2011) 11.08
Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med (1997) 8.59
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med (1999) 5.46
Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol (1993) 4.23
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J Clin Invest (1999) 3.83
Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol (2009) 3.19
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 3.08
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med (2003) 2.62
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy (2005) 2.55
Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med (2010) 2.35
Dendritic cells in vivo: a key target for a new vaccine science. Immunity (2008) 2.31
Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J Immunol (2001) 2.12
Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol (2011) 2.04
CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol (2000) 1.96
Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat Immunol (2007) 1.90
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.87
Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol (1993) 1.83
Molecular determinants of T cell epitope recognition to the common Timothy grass allergen. J Immunol (2010) 1.76
Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J Immunol Methods (2008) 1.62
IFN-γ- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J Exp Med (2011) 1.45
Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve. J Immunol (2008) 1.37
A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol (2004) 1.28
Direct ex vivo analysis of allergen-specific CD4+ T cells. J Allergy Clin Immunol (2010) 1.26
Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res (2010) 1.07
Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. J Allergy Clin Immunol (2012) 0.98
Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151. J Immunol (2005) 0.98
T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol (2010) 0.94
Mechanisms of immune tolerance to allergens. Chem Immunol Allergy (2012) 0.93
Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity. Int Arch Allergy Immunol (1993) 0.92
Mapping of T-cell epitopes of Phl p 5: evidence for crossreacting and non-crossreacting T-cell epitopes within Phl p 5 isoallergens. Clin Exp Allergy (1998) 0.90
Recombinant allergens rarely allow identification of Hymenoptera venom-allergic patients with negative specific IgE to whole venom preparations. J Allergy Clin Immunol (2014) 1.17
Arginine kinase Pen m 2 as an important shrimp allergen recognized by TH2 cells. J Allergy Clin Immunol (2014) 0.80
Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization. J Allergy Clin Immunol (2015) 0.78
Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjects. J Allergy Clin Immunol (2016) 0.76
Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy. J Allergy Clin Immunol (2015) 0.75
αS1-Casein elucidate major T-cell responses in cow's milk allergy. J Allergy Clin Immunol (2017) 0.75
Reply. J Allergy Clin Immunol (2016) 0.75